Wed, 30 Dec 2015 | MERGER
The sale of Sainsbury's pharmacies business to the Lloyds Pharmacy chain is under investigation by the UK's Competition and Markets Authority (CMA).
The investigations, which are likely to delay or halt the sale, have identified 78 local areas where the potential loss of market competition between Lloyds and Sainsbury's outlets could have an impact on consumers.
To address the matter, the CMA requested that Lloyds owner Celesio respond to the matter. This has yet to happen with no undertakings in lieu offered by the company and as such the merger is to be referred to an independent panel for an in-depth investigation.
Celesio appears confident that the deal will progress, stating: “While we accept there may be some geographical areas affected by a lessening of competition we do not believe it is as many as outlined by the CMA following its initial investigation.
“Therefore, we welcome a more detailed analysis and the opportunity to put our case forward.”
Meanwhile, Sainsbury's has said that it is continuing to work towards a deal completion date around the end of February, despite the fact that the full in-depth investigations from the CMW will not be revealed until 13 June.
The investigations do not mean that the sale will be halted, simply that further reassurances of consumer protection and maintenance of healthy competition will need to be provided.
View businesses for sale.
This is an opportunity to acquire the shares, business and/or assets of an electrophoretic and powder coating specialist located within the North East of England. Indicative proposals, supported by proof of funding, are accepted by no later than 4pm...
This unique holiday accommodation business offers distinctive, design-led stays on over 15 acres of private land, complete with exceptional amenities and a residential property. With a strong occupancy rate of over 90% and excellent guest reviews, it...
FREEHOLD
This exceptional opportunity allows you to acquire a leading UK business in pneumatic tube systems for healthcare, boasting exclusive distribution rights and strong client retention through multi-year service agreements.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.